BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 32661391)

  • 1. Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice.
    Suriben R; Chen M; Higbee J; Oeffinger J; Ventura R; Li B; Mondal K; Gao Z; Ayupova D; Taskar P; Li D; Starck SR; Chen HH; McEntee M; Katewa SD; Phung V; Wang M; Kekatpure A; Lakshminarasimhan D; White A; Olland A; Haldankar R; Solloway MJ; Hsu JY; Wang Y; Tang J; Lindhout DA; Allan BB
    Nat Med; 2020 Aug; 26(8):1264-1270. PubMed ID: 32661391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GDNF family receptor alpha-like antagonist antibody alleviates chemotherapy-induced cachexia in melanoma-bearing mice.
    Lee BY; Jeong J; Jung I; Cho H; Jung D; Shin J; Park JK; Park E; Noh S; Shin S; Kang S; Heo JI; Baek MC; Yea K
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1441-1453. PubMed ID: 37017344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GDF15 mediates adiposity resistance through actions on GFRAL neurons in the hindbrain AP/NTS.
    Tsai VW; Zhang HP; Manandhar R; Schofield P; Christ D; Lee-Ng KKM; Lebhar H; Marquis CP; Husaini Y; Brown DA; Breit SN
    Int J Obes (Lond); 2019 Dec; 43(12):2370-2380. PubMed ID: 31152154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates.
    Mullican SE; Lin-Schmidt X; Chin CN; Chavez JA; Furman JL; Armstrong AA; Beck SC; South VJ; Dinh TQ; Cash-Mason TD; Cavanaugh CR; Nelson S; Huang C; Hunter MJ; Rangwala SM
    Nat Med; 2017 Oct; 23(10):1150-1157. PubMed ID: 28846097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDF15: A Hormone Conveying Somatic Distress to the Brain.
    Lockhart SM; Saudek V; O'Rahilly S
    Endocr Rev; 2020 Aug; 41(4):. PubMed ID: 32310257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Obesity and Cachexia: Identification of the GFRAL Receptor-MIC-1/GDF15 Pathway.
    Breit SN; Tsai VW; Brown DA
    Trends Mol Med; 2017 Dec; 23(12):1065-1067. PubMed ID: 29129392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL.
    Emmerson PJ; Wang F; Du Y; Liu Q; Pickard RT; Gonciarz MD; Coskun T; Hamang MJ; Sindelar DK; Ballman KK; Foltz LA; Muppidi A; Alsina-Fernandez J; Barnard GC; Tang JX; Liu X; Mao X; Siegel R; Sloan JH; Mitchell PJ; Zhang BB; Gimeno RE; Shan B; Wu X
    Nat Med; 2017 Oct; 23(10):1215-1219. PubMed ID: 28846098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MIC-1/GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases.
    Tsai VWW; Husaini Y; Sainsbury A; Brown DA; Breit SN
    Cell Metab; 2018 Sep; 28(3):353-368. PubMed ID: 30184485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand.
    Yang L; Chang CC; Sun Z; Madsen D; Zhu H; Padkjær SB; Wu X; Huang T; Hultman K; Paulsen SJ; Wang J; Bugge A; Frantzen JB; Nørgaard P; Jeppesen JF; Yang Z; Secher A; Chen H; Li X; John LM; Shan B; He Z; Gao X; Su J; Hansen KT; Yang W; Jørgensen SB
    Nat Med; 2017 Oct; 23(10):1158-1166. PubMed ID: 28846099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GDF15-GFRAL Pathway in Health and Metabolic Disease: Friend or Foe?
    Breit SN; Brown DA; Tsai VW
    Annu Rev Physiol; 2021 Feb; 83():127-151. PubMed ID: 33228454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15.
    Hsu JY; Crawley S; Chen M; Ayupova DA; Lindhout DA; Higbee J; Kutach A; Joo W; Gao Z; Fu D; To C; Mondal K; Li B; Kekatpure A; Wang M; Laird T; Horner G; Chan J; McEntee M; Lopez M; Lakshminarasimhan D; White A; Wang SP; Yao J; Yie J; Matern H; Solloway M; Haldankar R; Parsons T; Tang J; Shen WD; Alice Chen Y; Tian H; Allan BB
    Nature; 2017 Oct; 550(7675):255-259. PubMed ID: 28953886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia.
    Siddiqui JA; Pothuraju R; Khan P; Sharma G; Muniyan S; Seshacharyulu P; Jain M; Nasser MW; Batra SK
    Cytokine Growth Factor Rev; 2022 Apr; 64():71-83. PubMed ID: 34836750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights Into Mechanisms of GDF15 and Receptor GFRAL: Therapeutic Targets.
    Rochette L; Zeller M; Cottin Y; Vergely C
    Trends Endocrinol Metab; 2020 Dec; 31(12):939-951. PubMed ID: 33172749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GDF15-GFRAL axis mediates chemotherapy-induced fatigue in mice.
    Chelette B; Chidomere CL; Dantzer R
    Brain Behav Immun; 2023 Feb; 108():45-54. PubMed ID: 36427806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of GDF15 peptide fragments inhibiting GFRAL receptor signaling.
    Alexopoulou F; Buch-Månson N; Pedersen SL; Vrang N; Fink LN; Strømgaard K
    Peptides; 2023 Oct; 168():171063. PubMed ID: 37495041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uniting GDF15 and GFRAL: Therapeutic Opportunities in Obesity and Beyond.
    Mullican SE; Rangwala SM
    Trends Endocrinol Metab; 2018 Aug; 29(8):560-570. PubMed ID: 29866502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice.
    Frikke-Schmidt H; Hultman K; Galaske JW; Jørgensen SB; Myers MG; Seeley RJ
    Mol Metab; 2019 Mar; 21():13-21. PubMed ID: 30685336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the divergent TGFβ superfamily cytokine MIC-1/GDF15 for therapy of anorexia/cachexia syndromes.
    Tsai VW; Brown DA; Breit SN
    Curr Opin Support Palliat Care; 2018 Dec; 12(4):404-409. PubMed ID: 30382947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GDF15-GFRAL pathway is dispensable for the effects of metformin on energy balance.
    Klein AB; Nicolaisen TS; Johann K; Fritzen AM; Mathiesen CV; Gil C; Pilmark NS; Karstoft K; Blond MB; Quist JS; Seeley RJ; Færch K; Lund J; Kleinert M; Clemmensen C
    Cell Rep; 2022 Aug; 40(8):111258. PubMed ID: 36001956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Camptothecin effectively treats obesity in mice through GDF15 induction.
    Lu JF; Zhu MQ; Xie BC; Shi XC; Liu H; Zhang RX; Xia B; Wu JW
    PLoS Biol; 2022 Feb; 20(2):e3001517. PubMed ID: 35202387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.